NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Developing Treatments to Fight Lung Cancer

Related Editorial
After thirty years of development, gene therapy is seeing a surge of progress and profitability.

Gene therapies tackle diseases by altering the genetic makeup of patients’ cells. Recent mergers and research developments make this a promising time to invest in the sector. Gene therapy companies are developing treatments for everything from cancer and HIV to skin diseases.

Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is developing treatments to tackle lung cancer. Spark Therapeutics Inc. (NASDAQ: ONCE), which recently entered a merger agreement with the Roche Group, targets ailments such as retinal and neurodegenerative diseases. Dyadic International Inc. (OTCQX: DYAI) is focused on finding uses for a fungal-based technology that could bring treatments to market faster. TrovaGene Inc. (NASDAQ: TROV) uses cell-level treatments to tackle cancer through inhibiting a specific enzyme. The technology developed by Novartis AG (NYSE: NVS) uses specific viruses to deliver treatment for a range of illnesses.

To view the full editorial, visit http://nnw.fm/2yq0K

To hear the NetworkNewsAudio version, visit http://nnw.fm/bw1cX

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.

About NetworkNewsAudio

NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps you informed on publicly traded companies we’re watching. The audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio is a Brand Awareness Distribution Solution from NetworkNewsWire.

For more information, visit www.NetworkNewsAudio.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

More Press Releases

The Latest: Mayoral hopefuls want explanation of prosecutors

Mar 27, 2019

CHICAGO — The Latest on the case against "Empire" actor Jussie Smollett (all times local): 7 p.m. The two candidates seeking to succeed Chicago Mayor Rahm Emanuel are asking for a more detailed explanation for the dropping of charges against "Empire" actor Jussie Smollett. Former federal prosecutor Lori Lightfoot says the public has to be told what the underlying basis was for the Cook County State's Attorney Office's decision Tuesday. Lightfoot noted when the charges against Smollett were announced, it looked like prosecutors had a very airtight case against the actor for allegedly staging a phony attack and claiming he...

Prosecutors dismiss charges against Smollett, draw backlash

Mar 27, 2019

CHICAGO — Infuriating Chicago's mayor and police chief, prosecutors abruptly dropped all charges against Jussie Smollett on Tuesday after the "Empire" actor accused of faking a racist, anti-gay attack on himself agreed to let the city keep his $10,000 in bail. But he maintained his innocence and insisted he was attacked. Prosecutors said they still believe Smollett concocted the assault. They gave no detailed explanation for why they abandoned the case only five weeks after filing the charges and threatening to pursue Smollett for the cost of a monthlong investigation. The dismissal drew an immediate backlash. Mayor Rahm Emanuel called...

Review: A symphony of debauchery in 'The Beach Bum'

Mar 27, 2019

Matthew McConaughey is at his dirt bag finest as a good-time Charlie stoner-poet named Moondog in Harmony Korine's "The Beach Bum," a bizarre and transfixing carnival of vulgarity and vice. In some ways it's the part he was born to play. Whether or not that's a good thing for him, or unsuspecting audiences, is unclear, but McConaughey gives and bares (nearly) all for this film. And it mostly works. Korine, with the help of his innately charismatic star and talented cinematographer Benoit Debie, nearly pulls off an incredible trick having made a flagrant and aggressively R-rated celebration of South Florida...

Judge dismisses some of Levine's claims against Met Opera

Mar 27, 2019

NEW YORK — A New York judge on Tuesday dismissed portions of a lawsuit filed by former Metropolitan Opera music director James Levine against the company last year. Levine was the Met's music or artistic director from 1976-2016, then became its music director emeritus. He was fired in March 2018 after the Met said an investigation found evidence of sexual abuse and harassment. Levine sued three days later, claiming breach of contract and defamation and seeking at least $5.8 million in damages. The Met moved last July to dismiss the defamation counts. New York Supreme Court Justice Andrea Masley on...

Cardi B responds to backlash over her drugging, robbing men

Mar 27, 2019

LOS ANGELES — Cardi B is trying to clarify herself after a video resurfaced online where the rapper said she drugged and robbed men for money. The Grammy winner posted a statement Tuesday on Instagram that she had "very limited options" and needed to do anything to "survive." The former stripper says she wasn't trying to glorify her actions, but felt it was necessary at the time. Cardi B is facing backlash from the Instagram Live video she says is from three years ago. Some on social media have criticized the rapper for her admission with the hashtag #SurvivingCardiB in...

Broaden News

Reporter Pass is the only access you need to get into Hollywood. No matter it’s the red carpet event or backstage access, we’ve got you covered.

Contact us: sales@reppass.com

Award ShowsCelebrityPaparazziRoyaltyMoviesMusicTelevision Programs Press Releases